How to ensure your data journey is FAIR
Pharma firms that stick to the principles of Findable, Accessible, Interoperable and Reusable data capture stand to benefit and get ahead of their competitors
Add bookmark
Many organizations in the life sciences space do not have the infrastructure in place to be able to capture data with context and then store it so that it can be searched and accessed with ease. Those businesses that do have the infrastructure in place, however, are better able to compete, innovate and overcome common research and discovery challenges.
By adhering to Findable, Accessible, Interoperable and Reusable (FAIR) principles, organizations will gain access to data that can be reused to ensure quality and speed in future research projects and will be better placeed to control their environment to provide partners with valuable insight.
This white paper from IDBS addresses the concerns of pharma businesses that have poor access to their own data and explains how they can change that via the FAIR principles, which have been recognized as standards that enable an organization to fully realize its data potential.
Share best practice, ideas, and solutions to our global community of more than 125,000 senior pharmaceutical and biotech professionals. View our latest Media Kit to learn more about our audience and review our content calendar. Download NowInterested in presenting your own Case Study?
Download this white paper to learn:
- How pharma businesses can capture data with context and gain full-picture insights.
- Why organizations should consider moving away from common data solutions that promise the right combination of buzzwords for a more rounded approach.
- How to ensure data is captured from the start and is easily accessible for future use.
